期刊文献+

脾内微量注射免疫法制备抗重组可溶性组织因子单克隆抗体 被引量:2

Preparation of anti-recombinant soluble tissue factor monoclonal antibody by trace injecting antigen into spleen
在线阅读 下载PDF
导出
摘要 目的制备抗重组可溶性组织因子(r-sTF)单克隆抗体并建立检测组织因子(TF)含量的夹心ELISA法,以期为TF的深入研究及临床应用提供参考依据。方法取微量TF对Balb/c小鼠直接进行脾内注射免疫,分离小鼠脾细胞和鼠骨髓瘤细胞,融合后对杂交瘤细胞进行筛选克隆化培养;建立了3株稳定分泌TF单克隆抗体的杂交瘤细胞株,分别命名为1-C3、2-G9、3-H9;进而在小鼠体内诱生腹水,并用rprotein A亲合层析法纯化;经鉴定后用过碘酸钠法将辣根过氧化物酶标记于其中一株单抗上,建立夹心ELISA法测定正常人血浆中的TF含量。结果纯化的单抗用SDS-PAGE测定纯度,在Mr为150 000左右呈现一条带;Western blot测定显示1-C3、2-G9、3-H9分泌的单抗可特异地识别Mr为47 000的TF,经免疫球蛋白(Ig)类和亚类鉴定实验证实3株单抗均为IgG1;用夹心ELISA法检测正常人血浆中的TF含量为(130±80)pg/mL。结论用脾内微量注射法成功制备抗TF单克隆抗体及ELISA测定TF含量方法的建立,为TF的制备纯化和检测奠定了基础,也使TF的临床深入化研究成为可能。 Purpose To prepare the anti-recombinant soluble tissue factor monoclonal antibody to develop an ELISA method which can be used to detect the tissue factor (TF) ; and to give a reference for going deep into the research and clinical application of TF. Methods We used TF to immunize Balb/ c mice by injecting TF into the spleen directly. Then the spleen cells were separated and fused with mouse myeloma cells(SP2/0) to obtain the hybridoma. The hybridoma was cloned and got 3 clones named as 1-C3, 2-G9, and 3-H9 which could stably secrete TF, and then they were embedded in mice bodies to induce ascites. TF was purified by protein A affinity chromatograph column and labeled with HRP. At last, normal humans' plasma TF levels were determined by ELISA developed from the antibody. Results The purified TF identified as IgG1 was a single band about Mr150 000 by SDS-PAGE analysis and Western blot showed that it could specifically recognize TF. Normal humans' plasma TF was about (130 ± 80)pg/mL as measured by ELISA. Conclusions We have prepared monoclonal antibody against TF and developed ELISA assays for TF successfully. The research will be useful for TF purification, measurements and clinical study.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2006年第1期92-96,共5页 Fudan University Journal of Medical Sciences
基金 教育部科学技术重点项目(105064) 上海市重大科技攻关项目(04DZ19104)资助
关键词 重组可溶性组织因子 免疫 单克隆抗体 recombinant soluble tissue factor immunity monoclonal antibody
  • 相关文献

参考文献6

  • 1Koyama T,Nishida K,Ohdama S.Determination of plasma tissue factor antigen and its clinical significance[J].Br J Haematol,1994,87(2):343.
  • 2Taubman BM,Fallon TJ,Schecter DA,et al.Tissue factor in the pathogenesis of atherosclerosis[J].Thomb Haemost,1997,78(1):200.
  • 3Mueller BM,reisfeld RA,Edgington TS,et al.Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis[J].Pro Nalt Acad Sci USA,1992,89(24):11832.
  • 4Friguet B,Chaffotte AF,Djavadio OL,et al.Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay[J].J Immunol Methods,1985,77(2):305.
  • 5Pawlinski R,Pedersen B.Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model[J].Blood,2003,101(10):3940.
  • 6Song KS,Kim HK.Plasma levels of tissue factor antigen in patients with non-insulin-dependent diabetes mellitus[J].Yonsei Med J,2004,45(1):38.

同被引文献31

  • 1李代宗,倪志华,赵晓瑜.兔脑组织因子基因在大肠杆菌中的克隆与表达[J].河北大学学报(自然科学版),2007,27(1):83-87. 被引量:5
  • 2上海太阳生物技术有限公司.临床检验凝血酶原时间(PT)测定体外诊断试剂盒:中国,1952169A[P].2007-04-25.
  • 3Baxter R Diagnostics Inc.Extraction methods for preparing thrombo-plastin reagent:US,5426031A[P/OL].1995-06- 20.http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch- bool.html&r=10&f=G&l=50&co1=AND&d=PTXT&s1=5426031&OS=5426031&RS=5426031.
  • 4Helena Laboratories Corporation.Method for preparing a thrombo-plastin extract:US,5512304A[P/OL].1996-04-30.http://pat- ft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch- bool.html&r=5&f=G&l=50&co1=AND&d=PTXT&s1=5512304&OS=5512304&RS=5512304.
  • 5Lifescan Inc.Method for manufacturing a tissue factor-based pro-thrombin time reagent:US,7049087[P/OL].2006-05-23.ht- tp://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch- bool.html&r=22&f=G&l=50&co1=AND&d=PTXT&s1=7049087&OS=7049087&RS=7049087.
  • 6Avocet Medical Inc.Test articles for performing dry reagent pro-thrombin time assays:US,5418141C1[P/OL].1995-05-23.ht- tp://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch- bool.html&r=29&f=G&l=50&co1=AND&d=PTXT&s1=5418141&OS=5418141&RS=5418141.
  • 7Andreas R.Thromboplastin reagent with long-term stability:US,20090162880A1[P].2009-06-25.
  • 8The Board of Trustees of the University of Illinois.Tissue factorcompositions and methods:US,7622437[P/OL].2009-11- 24.http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch- adv.htm&r=1&f=G&l=50&d=PTXT&S1=7622437&OS=7622437&RS=7622437.
  • 9复旦大学.重组可溶性组织因子及其制备方法和应用:中国,1496992A[P].2004-05-19.
  • 10太原博奥特生物技术有限公司.人重组组织因子的构建表达、纯化方法及其应用:中国,1687125A[P].2005-10-26.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部